doi: 10.1161/hs0402.105246
(Stroke. 2002;33:901.)
© 2002 American Heart Association, Inc.
Original Contributions |
Occurrence of Secondary Ischemic Events Among Persons With Atherosclerotic Vascular Disease
From RAND, Santa Monica, Calif (B.G.V., P.M.G., S.G., D.F.M.); Center for Health Care Policy and Evaluation, UnitedHealth Group, Minnetonka, Minn (T.S.R., S.L.W., R.A.L.); RAND, Washington, DC (E.M.S.); Rush Medical College, Chicago, Ill (P.B.G.); and Stanford University, Palo Alto, Calif (M.D.D.).
Reprint requests to Barbara G. Vickrey, MD, MPH, UCLA Department of Neurology, C128 RNRC, 710 Westwood, Box 951769, Los Angeles, CA 90095-1769. E-mail bvickrey{at}ucla.edu
Background and Purpose— Few data exist for large managed care populations on the occurrence of subsequent acute ischemic events in persons with established atherosclerotic vascular disease. We estimated the occurrence of secondary stroke, acute myocardial infarction (AMI), and vascular deaths among 2 large, managed care samples.
Methods— With the use of International Classification of Diseases, Ninth Revision, Clinical Modification codes, patients aged 
40 years and with stroke, AMI, or peripheral arterial disease (PAD) were identified from administrative data of UnitedHealthcare plans during 1995–1998. Stroke, AMI, and PAD cohorts were identified within a commercial insurance sample and a Medicare sample. Cumulative occurrences of subsequent stroke, AMI, or vascular death were estimated by survival analysis.
Results— In the stroke commercial cohort (n=1631; mean age, 62.1 years), cumulative occurrence of subsequent events was 4.2%, 6.5%, 9.8%, and 11.8% at 0.5, 1, 2, and 3 years, respectively; cumulative secondary event occurrence in the AMI commercial cohort (n=6458; mean age, 56.0 years) was 3.5%, 4.8%, 7.3%, and 8.5% and in the PAD commercial cohort (n=5813; mean age, 59.2 years) was 1.5%, 2.8%, 4.8%, and 6.5%, respectively. Cumulative secondary event occurrences were even higher in stroke (n=1518; mean age, 79.5 years), AMI (n=2197; mean age, 76.2 years), and PAD (n=5033; mean age, 76.6 years) cohorts of the Medicare sample: 18.1%, 17.0%, and 8.7%, respectively, at 3 years. More than 75% of each stroke cohort’s secondary events were strokes; more than 75% of each AMI cohort’s secondary events were AMIs. Of the PAD cohorts’ secondary events, 27% to 39% were strokes, 48% to 57% were AMIs, and 13% to 16% were vascular deaths.
Conclusions— Among these managed care enrollees with existing atherosclerotic vascular disease, subsequent ischemic events represent a significant symptomatic disease burden. Given these findings, it is very important to determine whether secondary prevention strategies are being effectively used to manage patients with diagnosed atherosclerosis.
Key Words: data interpretation, statistical • epidemiology • myocardial infarction • stroke
This article has been cited by other articles:
 |
|
 |
|
  A. E. Aquarius, K. G. Smolderen, J. F. Hamming, J. De Vries, P. W. Vriens, and J. Denollet Type D Personality and Mortality in Peripheral Arterial Disease: A Pilot Study Arch Surg, August 1, 2009; 144(8): 728 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Roberts, P. B. Gorelick, X. Ye, C. Harley, and G. A. Goldberg Additional Stroke-Related and Non-Stroke-Related Cardiovascular Costs and Hospitalizations in Managed-Care Patients After Ischemic Stroke Stroke, April 1, 2009; 40(4): 1425 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Brevetti, G. Sirico, G. Giugliano, S. Lanero, J. I. De Maio, R. Luciano, E. Laurenzano, and M. Chiariello Prevalence of hypoechoic carotid plaques in coronary artery disease: relationship with coexistent peripheral arterial disease and leukocyte number Vascular Medicine, February 1, 2009; 14(1): 13 - 19. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Amarenco and P. G. Steg Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention Eur. Heart J., July 1, 2008; 29(13): 1605 - 1607. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Bravata, S.-Y. Ho, T. P. Meehan, L. M. Brass, and J. Concato Readmission and Death After Hospitalization for Acute Ischemic Stroke: 5-Year Follow-Up in the Medicare Population Stroke, June 1, 2007; 38(6): 1899 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Liao Secondary Prevention of Stroke and Transient Ischemic Attack: Is More Platelet Inhibition the Answer? Circulation, March 27, 2007; 115(12): 1615 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Ph. G. Steg, D. L. Bhatt, P. W. F. Wilson, R. D'Agostino Sr, E. M. Ohman, J. Rother, C.-S. Liau, A. T. Hirsch, J.-L. Mas, Y. Ikeda, et al. One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis JAMA, March 21, 2007; 297(11): 1197 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ruland, D. Richardson, E. Hung, J. R. Brorson, S. Cruz-Flores, W. L. Felton III, G. Ford-Lynch, C. Helgason, C. Hsu, J. Kramer, et al. Predictors of recurrent stroke in African Americans. Neurology, August 22, 2006; 67(4): 567 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Stroke Prevention by Aggressive Reduction in C High-Dose Atorvastatin after Stroke or Transient Ischemic Attack N. Engl. J. Med., August 10, 2006; 355(6): 549 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Arima, C. Tzourio, K. Butcher, C. Anderson, M.-G. Bousser, K. R. Lees, J. L. Reid, T. Omae, M. Woodward, S. MacMahon, et al. Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial Stroke, June 1, 2006; 37(6): 1497 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fisher Results of the Management of Atherothrombosis With Clopidogrel in High-Risk Patients Trial: Implications for the Neurologist Arch Neurol, January 1, 2006; 63(1): 20 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kirshner, J. Biller, and A. S. Callahan III Long-Term Therapy to Prevent Stroke J Am Board Fam Med, November 1, 2005; 18(6): 528 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Kaplan, D. L. Tirschwell, W. T. Longstreth Jr, T. A. Manolio, S. R. Heckbert, D. Lefkowitz, A. El-Saed, and B. M. Psaty Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly Neurology, September 27, 2005; 65(6): 835 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Gebel Jr Secondary Stroke Prevention With Antiplatelet Therapy With Emphasis on the Cardiac Patient: A Neurologist's View J. Am. Coll. Cardiol., September 6, 2005; 46(5): 752 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Jamieson, A. Parekh, and M. D. Ezekowitz Review of Antiplatelet Therapy in Secondary Prevention of Cerebrovascular Events: A Need for Direct Comparisons Between Antiplatelet Agents Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2005; 10(3): 153 - 161. [Abstract] [PDF]
|
|
|
|
|
|
D. L. Brown, L. D. Lisabeth, C. Roychoudhury, Y. Ye, and L. B. Morgenstern Recurrent Stroke Risk Is Higher Than Cardiac Event Risk After Initial Stroke/Transient Ischemic Attack Stroke, June 1, 2005; 36(6): 1285 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Parekh, L. Zhang, B. A. Fivush, and M. J. Klag Incidence of Atherosclerosis by Race in the Dialysis Morbidity and Mortality Study: A Sample of the US ESRD Population J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1420 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Gordon, M. Gulanick, F. Costa, G. Fletcher, B. A. Franklin, E. J. Roth, and T. Shephard Physical Activity and Exercise Recommendations for Stroke Survivors: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council Stroke, May 1, 2004; 35(5): 1230 - 1240. [Full Text] [PDF]
|
|
|
|
|
|
N. F. Gordon, M. Gulanick, F. Costa, G. Fletcher, B. A. Franklin, E. J. Roth, and T. Shephard Physical Activity and Exercise Recommendations for Stroke Survivors: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council Circulation, April 27, 2004; 109(16): 2031 - 2041. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Adams, M. I. Chimowitz, J. S. Alpert, I. A. Awad, M. D. Cerqueria, P. Fayad, and K. A. Taubert Coronary Risk Evaluation in Patients With Transient Ischemic Attack and Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association Circulation, September 9, 2003; 108(10): 1278 - 1290. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Adams, M. I. Chimowitz, J. S. Alpert, I. A. Awad, M. D. Cerqueria, P. Fayad, and K. A. Taubert Coronary Risk Evaluation in Patients With Transient Ischemic Attack and Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association Stroke, September 1, 2003; 34(9): 2310 - 2322. [Full Text] [PDF]
|
|